EDN1 and Hypertension: Some reports propose that changes in vasoactive molecules, such as reduced NO bioavailability 23, excessive oxidative stress 24, increased levels of angiotensin II and endothelin-1 25, 26, regulate endothelial function during the development of hypertension following CIH.